Xeris Biopharma Holdings (NASDAQ:XERS) is set to give its latest quarterly earnings report on Monday, 2026-03-02. Here’s what investors need to know before the announcement.
Analysts estimate that Xeris Biopharma Holdings will report an earnings per share (EPS) of $0.04.
Investors in Xeris Biopharma Holdings are eagerly awaiting the company’s announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.
It’s worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.
Performance in Previous Earnings
During the last quarter, …